Evonik Industries AG (ETR:EVK) | Finanzwire

Basculer en Français

11218	Companies
248750	Keywords
176526	Articles
134592	Press releases

Home
Companies
Evonik Industries AG

BRIEF

published on 10/06/2026 at 16:35, 16 days 7 hours ago

Evonik Industries AG Receives "Hold" Recommendation from Parmantier & Cie. GmbH

Evonik Industries "Hold" Recommendation German Chemicals Sector 2027 Economic Cycle Parmantier & Cie. Report
PRESS RELEASE

published on 10/06/2026 at 16:30, 16 days 8 hours ago

Original-Research: Evonik Industries AG (von Parmantier & Cie. GmbH): Hold
Parmantier & Cie. Research presents 'European Chemicals: The 2027 Cycle', a detailed 76-page knowledge report and primer on the German chemicals sector, offering insights and recommendations for institutional investors

Institutional Investors PARMANTIER & CIE. 2027 Cycle European Chemicals German Chemicals Sector
BRIEF

published on 09/25/2026 at 15:17, 27 days 9 hours ago

Evonik Acknowledges BASF's Non-Binding Takeover Approach

Merger Investor Relations Takeover Offer BASF Evonik
PRESS RELEASE

published on 09/25/2026 at 15:12, 27 days 9 hours ago

EQS-Adhoc: Evonik Industries AG confirms receipt of a non-binding approach from BASF SE regarding a potential takeover offer
Evonik Industries AG confirms receipt of a non-binding approach from BASF SE regarding a potential takeover offer. No current talks are ongoing

Acquisitions Takeover Offer Mergers Evonik Industries AG BASF SE
BRIEF

published on 08/28/2026 at 09:10, 1 month 25 days ago

Evonik Boosts Lipid-Based Drug Delivery in Vancouver

Biotech Innovation Evonik Vancouver GMP Facility Lipid-based Drugs
PRESS RELEASE

published on 08/28/2026 at 09:05, 1 month 25 days ago

Evonik expands lipid-based drug delivery capabilities with new GMP manufacturing facility in Vancouver
Evonik invests over 150 million CAD in new GMP manufacturing facility in Vancouver to expand lipid-based drug delivery capabilities, with Canadian government funding support

Evonik Vancouver GMP Manufacturing Facility Lipid-based Drug Delivery Canadian Government Funding
BRIEF

published on 07/08/2026 at 14:10, 3 months 14 days ago

Evonik Invests US$100 Million to Enhance U.S. Manufacturing Site

U.S. Manufacturing Pharmaceutical Ingredients Evonik Investment Automation Enhancement Next Generation Technologies
PRESS RELEASE

published on 07/08/2026 at 14:05, 3 months 14 days ago

Evonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site
Evonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site, enhancing capabilities and meeting growing demand for CDMOs

CDMO Investment Evonik US Drug Substance
BRIEF

published on 06/26/2026 at 11:19, 3 months 26 days ago

Evonik Industries AG Adjusts 2026 Financial Outlook Upwards

Supply Chain Disruptions EBITDA Growth Evonik Industries Financial Forecast 2026 Cash Flow Target
PRESS RELEASE

published on 06/26/2026 at 11:14, 3 months 26 days ago

EQS-Adhoc: Evonik Industries AG: Current financial and forecast data for the second quarter of 2026 and adjustment of the outlook for the financial year 2026
Evonik Industries AG releases financial data and adjusts outlook for 2026, expecting adjusted EBITDA to rise between €2.0-€2.2 billion, driven by sales growth and cost reductions

Adjusted EBITDA Cost Reductions Financial Data Evonik Industries Outlook 2026

Accesswire

Published on 10/22/2026 at 23:30, 1 hour 2 minutes ago

Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 2 hours 2 minutes ago

Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 8 hours 32 minutes ago

Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 10 hours 2 minutes ago

Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/22/2026 at 14:00, 10 hours 32 minutes ago

Jericho Energy Ventures Amends Investor Relations Agreement with Orange Group Advisors

View all ACCESSWIRE

EQS Group

Published on 10/22/2026 at 22:10, 2 hours 21 minutes ago

Quantinuum to Report Third Quarter Financial Results on November 5, 2026
Published on 10/22/2026 at 20:00, 4 hours 32 minutes ago

Exchange offer for Eleving Group 2023/2028 bonds (ISIN DE000A3LL7M4) completed
Published on 10/22/2026 at 18:45, 5 hours 46 minutes ago

Swedish Export Credit Corporation (SEK): Europe's defence build-up opens opportunities for Swedish companies in Germany
Published on 10/22/2026 at 18:12, 6 hours 19 minutes ago

LION E-Mobility AG: CEO Dr. Joachim Damasky to retire at the end of January 2027
Published on 10/22/2026 at 18:10, 6 hours 21 minutes ago

EQS-Adhoc: LION E-Mobility AG: CEO Dr. Joachim Damasky to retire at the end of January 2027

Les Echos

Published on 10/22/2026 at 18:00, 6 hours 32 minutes ago

THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 6 hours 32 minutes ago

bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 6 hours 32 minutes ago

H1 2026: marked improvement in operating results
Published on 10/22/2026 at 17:47, 6 hours 44 minutes ago

Aéroports de Paris SA - 2026 9-month revenue
Published on 10/22/2026 at 17:45, 6 hours 47 minutes ago

Third-quarter 2026 : Accor upgrades its EBITDA guidance

View all LES ECHOS COMFI WIRE